Neurocrine Biosciences (NBIX) Goodwill & Intangibles (2022 - 2025)

Neurocrine Biosciences has reported Goodwill & Intangibles for 4 years, with the latest figure at $35.7 million in Q3 2025.

• For the quarter ending Q3 2025, Goodwill & Intangibles fell 12.07% year-over-year to $35.7 million; the trailing twelve-month figure through Sep 2025 stood at $35.7 million (down 12.07% YoY), and the FY2024 full-year result was $42.2 million, up 2.18% from the prior year.
• Goodwill & Intangibles for Q3 2025 stood at $35.7 million, down from $37.2 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $42.8 million in Q1 2023, with the low at $35.7 million in Q3 2025.
• Historically, Goodwill & Intangibles has averaged $40.1 million across 4 years, with a median of $40.5 million in 2023.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles rose 2.18% — and 2025, when it dropped 12.07%.
• Neurocrine Biosciences' Goodwill & Intangibles stood at $42.6 million in 2022, then decreased by 3.05% to $41.3 million in 2023, then rose by 2.18% to $42.2 million in 2024, then decreased by 15.4% to $35.7 million in 2025.
• The last three Goodwill & Intangibles figures came in at $35.7 million (Q3 2025), $37.2 million (Q2 2025), and $36.4 million (Q1 2025), per Business Quant data.